Microbeads and flow cytometry: How and why put the «-metry» into flow cytometry?;Microbilles et cytométrie: Comment et pourquoi introduire la «-métrie» dans l'immuno-cytométrie?

Annales de Biologie Clinique

Volumn 62, Issue 1, 2004, Pages 53-57

  Poncelet, P ^a  

^a Biocytex   (France)

Author keywords

Antigen quantitation; Calibration beads; Quantitative flow cytometry; Quantitative immuno phenotype

Indexed keywords

MICROSPHERE;

CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGICAL PROCEDURES; INSTRUMENTATION; METHODOLOGY; REVIEW;

CYTOLOGICAL TECHNIQUES; FLOW CYTOMETRY; IMMUNOLOGIC TECHNIQUES; MICROSPHERES;

EID: 1242310630     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Lenkei R, Mandy F, Marti G, Vogt B. Quantitative fluorescence cytometry: an emerging consensus. Cytometry 1998 ; 33 : 96-287.
2. Hadam MR. 7th international workshop on human leucocyte differentiation antigens CD antigens section internet: www.mh -hannover.de/ aktuelles/projekte/ hlda7/hldabase/select.htm
3. Poncelet P, George F, Papa S, Lanza F. Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem 1996 ; 40 (Suppl. 1): 15-32*.
4. Poncelet P, Besson-Faure I, Lavabre-Bertrand T. Clinical applications of quantitative immunophenotyping. In : Stewart CC, Nicholson JKA, eds. Immunophenotyping. New-York : Wiley-Liss, 2000 : 105-32*.
5. Schwartz A, Marti GE, Poon R, et al. Standardizing flow cytometry : a classification system of fluorescence standards used for flow cytometry. Cytometry 1998 ; 33 : 106-14.
6. Schwartz A, Fernandez-Repollet E. Quantitative immunophenotyping. In : Stewart CC, Nicholson JKA, eds. Immunophenotyping. New-York : Wiley-Liss, 2000 : 83-104.
7. Gratama JW, d'Hautcourt JL, Mandy F, et al. Flow cytometric quantitation of immunofluorescence intensity : problems and perspectives. Cytometry 1998 ; 33 : 166-78.
8. Redelman D. Flow cytometric analyses of cell phenotypes. In : Stewart CC, Nicholson JKA, eds. Immunophenotyping. New-York : Wiley-Liss, 2000 : 49-104.
9. Davis K, Abrams B, Iyer S, Hoffman RA, Bishop JE. Determination of CD4 antigen density on cells : role of antibody valency, avidity, clones and conjugation. Cytometry 1998 ; 33 : 197-205.
10. Serke S, van Lessen A, Huhn D. Quantitative fluorescence flow cytometry : a comparison of three techniques for direct and indirect immunofluorescence. Cytometry 1998 ; 33 : 179-87.
11. Bikoue A, Janossy G, Barnett D. Stabilised cellular immunofluorescence assay : CD45 expression as a calibration standard for human leukocytes. J Immunol Methods 2002 ; 266 : 19-32.
12. Poncelet P, Carayon P. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal anti-bodies. J Immunol Methods 1985 ; 85 : 65-75.
13. Roederer M, Herzenberg LA. Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. Int Immunol 1996 ; 8 : 1-11.
14. Besson I, Camoin-Jau L. Quantification d'antigènes de surface par cytométrie en flux : exploration des plaquettes. Rev Fr Lab 1996 ; 287 : 91-5.
15. Drouin J, Leduc M. Quantitation of surface antigens in two giant platelet syndromes using flow cytometry. Thromb Haemost 1997 ; Suppl : 67.
16. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin alpha2-beta3 density is associated with two silent polymorphism in the alpha-2 gene coding sequence. Blood 1997 ; 89 : 1939-43.
17. Santoro SA. Platelet surface collagen receptor polymorphisms : variable receptor expression and thrombotic/hemorrhagic risk. Blood 1999 ; 93 : 3575-7.
18. Corral J, Gonzales-Conejero R, Rivera J, Ortuno F, Aparicio P, Vicente V. Role of the 807 C/T polymorphism of the a2 gene in platelet GpIa collagen receptor expression and function. Effect in thromboembolic diseases. Thromb Haemost 1999 ; 81 : 951-6.
19. Dupont A, Fontana P, Bachelot-Loza C, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003 ; 101 : 1833-40.
20. Schlegel N, Fenneteau O, Goulevestre C, et al. The interest of quantitative flow cytometry kits for the identification and characterization of inherited platelet disorders. Blood 1998 ; 92 : 10 (Suppl. 1) : 3367.
21. Moran N, Morateck PA, Deering A, et al. Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta : evidence from a novel mutation causing Bernard-Soulier syndrome. Blood 2000 ; 96 : 532-9.
22. Nair S, Ghosh K, Kulkarni B, Shetty S, Mohanty D. Glanzmann's thrombasthenia : updated. Platelets 2002 ; 13 : 387-93.
23. Hézard N, Amory C, Leroux B, Schlegel N, Potron G, N'Guyen P. Platelet hyporeactivity in healthy children remains beyond the neonatal period. Blood 2002 ; 100 : 691a.
24. Schooneman F, Claise C, Latger V, Stoldtz JF. Plaquettes et conservation : analyse des marqueurs membranaires de trois concentrés de plaquettes d'aphérèse. Transf Clin Biol 1998 ; 5 (Suppl. 1) ; O16-3.
25. Starke R, Cramer E, Harrison P. Expression of cell-associated prion protein on normal human platelets. Br J Haematol 2000 ; 110 : 748-50.
26. Ledford MR, Canton M, Preston R, et al. Monitoring by three laboratory methods of an oral GpIIb/IIIa anti- platelet agent in patients with vascular disease. Thromb Haemost 1999 ; (Suppl. August) : 2601.
27. Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald DJ. Quantifying GpIIb/IIIa receptor binding using two monoclonal antibodies. Discriminating abciximab and small molecular weight antagonists. Circulation 1999 ; 99 : 2231-8.
28. Hézard N, Metz D, Nazeyrollas P, et al. Free and total platelet glycoprotein IIb/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA. Thromb Haemost 1999 ; 81 : 869-73.
29. Miet S, Moro T, Boulay-Moine D, et al. Platelet HPA-1 : un test simple et rapide pour l'analyse du polymorphisme HPA-1 par cytométrie en flux quantitative. Transf Clin Biol 1998 ; 5 (Suppl. 1) : P12-7.
30. Taylor JM, Besson-Faure I, Canton M, Cler LM, Triplett D. Validation of a new method for platelet HPA-1 phenotyping. Thromb Haemost 1999 ; 82 (Suppl.) : 159.
31. Schwippert-Houtermans B. Evaluation of an antibody-based genotype classification of the platelet fibrinogen receptor (GPIIb/IIIa). Cytometry 2001 ; 46 : 238-42.
32. Ostendorf N, Stahl D, Sibrowski W. Implementation of a flow cytometric assay for rapid detection of HPA-1-compatible platelet donors under routine conditions. Infus Ther Transfus Med 2002 ; 29 : 6-10.
33. Barclay GR, Hope J, Birkett CR, Turner ML. Distribution of cell-associated prion protein in normal adult blood determined bu flow cytometry. Br J Haematol 1999 ; 107 : 804-14.
34. Latger V, Dumas D, Lecompte T, Potron G, Stoltz JF. Pathologie vasculaire et activation cellulaire. Exploration du phénotype cellulaire adhérent par cytométrie en flux quantitative. J Mal Vasc 1999 ; 24 : 11-8.
35. Dou L, Cerini C, Brunet P, et al. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002 ; 62 : 1999-2009.
36. Best D, Senis YA, Jarvis GE, et al. GPVI levels in platelets : relationship to platelet function at high shear. Blood 2003 ; 102 : 2811-8.
37. Moal V, Brunet P, Dou L, et al. Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients. Nephrol Dial Transplant 2003 ; 18 : 1834-41.
38. Zidovec LS, Vince A, Dakovic RO, et al. Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 2003 ; 133 : 384-90.